Novartis Ag (NVS) Assets Average (2018 - 2025)
Novartis Ag (NVS) has disclosed Assets Average for 8 consecutive years, with $106.6 billion as the latest value for Q4 2025.
- Quarterly Assets Average rose 5.44% to $106.6 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $106.6 billion through Dec 2025, up 5.44% year-over-year, with the annual reading at $106.6 billion for FY2025, 5.44% up from the prior year.
- Assets Average hit $106.6 billion in Q4 2025 for Novartis Ag, up from $101.1 billion in the prior quarter.
- In the past five years, Assets Average ranged from a high of $129.8 billion in Q4 2021 to a low of $101.1 billion in Q4 2024.
- Historically, Assets Average has averaged $114.2 billion across 5 years, with a median of $108.7 billion in 2023.
- Biggest five-year swings in Assets Average: rose 5.45% in 2021 and later fell 12.78% in 2023.
- Year by year, Assets Average stood at $129.8 billion in 2021, then fell by 3.98% to $124.6 billion in 2022, then fell by 12.78% to $108.7 billion in 2023, then dropped by 7.0% to $101.1 billion in 2024, then grew by 5.44% to $106.6 billion in 2025.
- Business Quant data shows Assets Average for NVS at $106.6 billion in Q4 2025, $101.1 billion in Q4 2024, and $108.7 billion in Q4 2023.